Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription 25.04.2022 1 Am Heart J 3 Am J Cardiol 1 Anesth Analg 4 Angiology 1 Ann Intern Med 1 Ann Thorac Surg 1 Arterioscler Thromb Vasc Biol 22 Catheter Cardiovasc Interv 1 Chest 3 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 2 Circ Genom Precis Med 3 Circ Heart Fail 8 Circulation 8 Eur Heart J 5 Int J Cardiol 6 J Am Coll Cardiol 1 J Cardiovasc Pharmacol 2 J Clin Endocrinol Metab 1 J Nucl Med 5 J Thorac Cardiovasc Surg 1 JAMA 1 Mayo Clin Proc 4 N Engl J Med 1 PLoS Comput Biol 2 PLoS One 1 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. GARG A, Rout A, Farhan S, Waxman S, et al
   Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
   Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. KUMAR P, Kim JS, Gordin J, Honda HM, et al
   Fractional Flow Reserve in End-Stage Liver Disease.
   Am J Cardiol. 2022;166:122-126.
   PubMed         Abstract available
   
   
3. MIURA K, Tanaka H, Kishi K, Muramatsu T, et al
   Impact of Timing and Treatment Strategy on Coronary Perforation During Percutaneous Coronary Intervention for Chronic Total Occlusion.
   Am J Cardiol. 2022 Apr 13. pii: S0002-9149(22)00170.
   PubMed         Abstract available
   
   
4. KRITTANAWONG C, Yue B, Mahtta D, Narasimhan B, et al
   Readmission in Patients With ST-Elevation Myocardial Infarction in 4 Age Groups (<45, >45 to <60, 60 to <75, and >75).
   Am J Cardiol. 2022 Apr 14. pii: S0002-9149(22)00239.
   PubMed         Abstract available
   
   

   
   Anesth Analg

5. PARK S, Nam K, Kim TK
   Association Between Preoperative Fibrinogen-to-Albumin Ratio and All-Cause Mortality After Off-Pump Coronary Artery Bypass Grafting: A Retrospective Observational Study.
   Anesth Analg. 2022;134:1021-1027.
   PubMed         Abstract available
   
   

   
   Angiology

6. BRIASOULIS A, Kampaktsis P, Emfietzoglou M, Kuno T, et al
   Temporary Mechanical Circulatory Support in Cardiogenic Shock due to ST-Elevation Myocardial Infarction: Analysis of the National Readmissions Database.
   Angiology. 2022 Apr 20:33197221091641. doi: 10.1177/00033197221091641.
   PubMed         Abstract available
   
   
7. SAYLIK F, Cinar T, Akbulut T, Selcuk M, et al
   Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
   Angiology. 2022 Apr 22:33197221091605. doi: 10.1177/00033197221091605.
   PubMed         Abstract available
   
   
8. TURKYILMAZ E, Ozkalayci F, Birdal O, Karagoz A, et al
   Serum Albumin to Creatinine Ratio and Short-Term Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction.
   Angiology. 2022 Apr 22:33197221089423. doi: 10.1177/00033197221089423.
   PubMed         Abstract available
   
   
9. DEMIRELLI S, Md KAT, Tasolar H, Calapkorur B, et al
   Assessment of a New Electrocardiographic Marker for the Diagnosis of Myocardial Infarction With Non-obstructive Coronary Arteries.
   Angiology. 2022 Apr 22:33197221089373. doi: 10.1177/00033197221089373.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

10. HOLT A, Blanche P, Jensen AKG, Nouhravesh N, et al
    Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study.
    Ann Intern Med. 2022 Apr 19. doi: 10.7326/M21-3445.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

11. ISHIKAWA N, Watanabe G, Horikawa T, Seguchi R, et al
    Robot-assisted totally-endoscopic mitral valve plasty and coronary artery bypass grafting.
    Ann Thorac Surg. 2022 Apr 18. pii: S0003-4975(22)00523.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

12. LORENTZEN LG, Hansen GM, Iversen KK, Bundgaard H, et al
    Proteomic Characterization of Atherosclerotic Lesions In Situ Using Percutaneous Coronary Intervention Angioplasty Balloons.
    Arterioscler Thromb Vasc Biol. 2022 Apr 21:101161ATVBAHA122317491.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

13. PARIKH PB, Reilly JP
    Outcomes with early opioid administration in acute coronary syndromes: Does sex matter?
    Catheter Cardiovasc Interv. 2022;99:996-997.
    PubMed        
    
    
14. DANGAS G, Garg A
    Double kissing crush stenting: No pain, no gain?
    Catheter Cardiovasc Interv. 2022;99:1045-1046.
    PubMed        
    
    
15. JENTZER JC, Soussi S, Lawler PR, Kennedy JN, et al
    Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population.
    Catheter Cardiovasc Interv. 2022;99:1006-1014.
    PubMed         Abstract available
    
    
16. MEJIA-RENTERIA H, Faria D, Lee JM, Lee SH, et al
    Association between patient age, microcirculation, and coronary stenosis assessment with fractional flow reserve and instantaneous wave-free ratio.
    Catheter Cardiovasc Interv. 2022;99:1104-1114.
    PubMed         Abstract available
    
    
17. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    PubMed         Abstract available
    
    
18. NAN TIE E, Fernando H, Nehme Z, Dinh D, et al
    Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes.
    Catheter Cardiovasc Interv. 2022;99:989-995.
    PubMed         Abstract available
    
    
19. HANSEN KN, Maeng M, Raungaard B, Engstrom T, et al
    Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
    Catheter Cardiovasc Interv. 2022;99:1095-1103.
    PubMed         Abstract available
    
    
20. BARKHOLT TO, Neghabat O, Holck EN, Andreasen LN, et al
    Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Catheter Cardiovasc Interv. 2022;99:1075-1083.
    PubMed         Abstract available
    
    
21. WILLIAMS T, Mittal A, Karageorgiev D, Iniguez Romo A, et al
    Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry.
    Catheter Cardiovasc Interv. 2022;99:961-967.
    PubMed         Abstract available
    
    
22. TAKAHASHI T, Nishi T, Zimmermann FM, Granada JF, et al
    Clinical validation of a novel simplified offline tool for SYNTAX score calculation.
    Catheter Cardiovasc Interv. 2022;99:1366-1368.
    PubMed        
    
    
23. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    PubMed         Abstract available
    
    
24. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    PubMed         Abstract available
    
    
25. TARANTINI G, Cardaioli F
    Bioresorbable scaffolds: zebras are not striped horses.
    Catheter Cardiovasc Interv. 2022;99:1084-1085.
    PubMed        
    
    
26. BISCAGLIA S, Erriquez A, Serenelli M, D'Ascenzo F, et al
    Complete versus culprit-only strategy in older MI patients with multivessel disease.
    Catheter Cardiovasc Interv. 2022;99:970-978.
    PubMed         Abstract available
    
    
27. PATEL NJ, Heuser RR
    Physiologic liquid plumber: A novel treatment to facilitate crossing of chronic total occlusions.
    Catheter Cardiovasc Interv. 2022;99:1074.
    PubMed        
    
    
28. GRINES CL, Marshall JJ
    Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease.
    Catheter Cardiovasc Interv. 2022;99:968-969.
    PubMed        
    
    
29. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    PubMed         Abstract available
    
    
30. SIMSEK B, Kostantinis S, Karacsonyi J, Vemmou E, et al
    Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;99:1038-1044.
    PubMed         Abstract available
    
    
31. SPIRITO A, Mehran R
    Elderly patients with acute myocardial infarction: Targeted or complete revascularization?
    Catheter Cardiovasc Interv. 2022;99:979-980.
    PubMed        
    
    
32. HILLERSON D, Whiteside HL, Dugan AJ, Coots RD, et al
    Predicting mortality in nonsurgical patients before cannulation for veno-arterial extracorporeal life support: Development and validation of the LACT-8 score.
    Catheter Cardiovasc Interv. 2022;99:1115-1124.
    PubMed         Abstract available
    
    
33. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    PubMed        
    
    
34. GRAHAM JJ, Bagai A, Wijeysundera H, Weisz G, et al
    Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial.
    Catheter Cardiovasc Interv. 2022;99:1065-1073.
    PubMed         Abstract available
    
    

    
    Chest

35. BURSTEIN B, van Diepen S, Wiley BM, Anavekar NS, et al
    Biventricular function and shock severity predict mortality in cardiac intensive care unit patients.
    Chest. 2021 Oct 2. pii: S0012-3692(21)04073-3. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

36. LEE YJ, Zhang JJ, Mintz GS, Hong SJ, et al
    Is Routine Postdilation During Angiography-Guided Stent Implantation as Good as Intravascular Ultrasound Guidance?: An Analysis Using Data From IVUS-XPL and ULTIMATE.
    Circ Cardiovasc Interv. 2022;15:e011366.
    PubMed         Abstract available
    
    
37. SABBAH M, Joshi FR, Minkkinen M, Holmvang L, et al
    Long-Term Changes in Invasive Physiological Pressure Indices of Stenosis Severity Following Transcatheter Aortic Valve Implantation.
    Circ Cardiovasc Interv. 2021 Nov 23:CIRCINTERVENTIONS121011331.
    PubMed         Abstract available
    
    
38. TEHRANI D, Seto AH
    Ejection Fraction as the Key to Improvement in Ischemic Cardiomyopathy Outcomes.
    Circ Cardiovasc Interv. 2022;15:e012000.
    PubMed        
    
    

    
    Circ Cardiovasc Qual Outcomes

39. WANG N, Woodward M, Huffman MD, Rodgers A, et al
    Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis.
    Circ Cardiovasc Qual Outcomes. 2022 Apr 18:101161CIRCOUTCOMES121008552.
    PubMed         Abstract available
    
    

    
    Circ Genom Precis Med

40. GORZYNSKI JE, Goenka SD, Shafin K, Jensen TD, et al
    Ultra-Rapid Nanopore Whole Genome Genetic Diagnosis of Dilated Cardiomyopathy in an Adolescent With Cardiogenic Shock.
    Circ Genom Precis Med. 2022;15:e003591.
    PubMed        
    
    
41. 
    Correction to: Cupido et al, Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization.
    Circ Genom Precis Med. 2022 Apr 22:101161HCG0000000000000089.
    PubMed        
    
    

    
    Circ Heart Fail

42. VALLABHAJOSYULA S, Katz JN, Menon V
    Quantification of Vasoactive Medications and the "Pharmaco-Mechanical Continuum" in Cardiogenic Shock.
    Circ Heart Fail. 2022;15:e008736.
    PubMed        
    
    
43. AONUMA T, Moukette B, Kawaguchi S, Barupala NP, et al
    MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic Hoxa4.
    Circ Heart Fail. 2022;15:e008686.
    PubMed         Abstract available
    
    
44. ARAJ FG, Hackmann AE
    Letter by Araj and Hackmann Regarding Article, "Liberation From Venoarterial Extracorporeal Membrane Oxygenation: A Review".
    Circ Heart Fail. 2022;15:e009079.
    PubMed        
    
    

    
    Circulation

45. 
    Correction to: Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
    Circulation. 2022;145:e841.
    PubMed        
    
    
46. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    PubMed         Abstract available
    
    
47. WHITE HD
    Zooming in on the Enigmas of Type 2 Myocardial Infarction.
    Circulation. 2022;145:1201-1204.
    PubMed        
    
    
48. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    PubMed         Abstract available
    
    
49. CHEN R, Jiang Y, Hu J, Chen H, et al
    Hourly Air Pollutants and Acute Coronary Syndrome Onset In 1.29 Million Patients.
    Circulation. 2022 Apr 22. doi: 10.1161/CIRCULATIONAHA.121.057179.
    PubMed         Abstract available
    
    
50. FENG G, Bajpai G, Ma P, Koenig A, et al
    CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
    Circulation. 2022;145:765-782.
    PubMed         Abstract available
    
    
51. KUEHN BM
    Higher Risk of Heart Disease Among South Asians Calls for Targeted Interventions.
    Circulation. 2022;145:1020-1021.
    PubMed        
    
    
52. JIA D, Chen S, Bai P, Luo C, et al
    Cardiac Resident Macrophage-derived Legumain Improves Cardiac Repair via Promoting Clearance and Degradation of Apoptotic Cardiomyocytes after Myocardial Infarction.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057549.
    PubMed         Abstract available
    
    

    
    Eur Heart J

53. MORICI N, De Servi S, De Luca L, Crimi G, et al
    Management of acute coronary syndromes in older adults.
    Eur Heart J. 2022;43:1542-1553.
    PubMed         Abstract available
    
    
54. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    PubMed        
    
    
55. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    PubMed         Abstract available
    
    
56. CREA F
    Inflammation, targeted proteomics, and microvascular dysfunction: the new frontiers of ischaemic heart disease.
    Eur Heart J. 2022;43:1517-1520.
    PubMed        
    
    
57. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    PubMed        
    
    
58. STEFFENS S, Nahrendorf M, Madonna R
    Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies.
    Eur Heart J. 2022;43:1533-1541.
    PubMed         Abstract available
    
    
59. WHITE HD, Schwartz GG, Szarek M, Bhatt DL, et al
    Alirocumab after acute coronary syndrome in patients with a history of heart failure.
    Eur Heart J. 2021 Dec 18. pii: 6469637. doi: 10.1093.
    PubMed         Abstract available
    
    
60. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

61. AKIMARU K, Iwabuchi M, Ishida A, Uehara H, et al
    Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention.
    Int J Cardiol. 2022;356:30-35.
    PubMed         Abstract available
    
    
62. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    PubMed        
    
    
63. KAVSAK PA, Mondoux SE, Ainsworth C, Worster A, et al
    High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI.
    Int J Cardiol. 2022;356:36-37.
    PubMed        
    
    
64. ROONGSANGMANOON W, Wongsoasup A, Angkananard T, Rattanajaruskul N, et al
    Comparison of efficacy and safety of intracoronary nicardipine and adenosine for fractional flow reserve assessment of coronary stenosis.
    Int J Cardiol. 2022;356:1-5.
    PubMed         Abstract available
    
    
65. MIR T, Uddin M, Changal K, Qureshi W, et al
    Mortality outcomes and 30-day readmissions associated with coronary artery aneurysms; a National Database Study.
    Int J Cardiol. 2022;356:6-11.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

66. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.
    J Am Coll Cardiol. 2022;79:1458-1473.
    PubMed         Abstract available
    
    
67. GRANGER CB, Krychtiuk KA, Gersh BJ
    Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short.
    J Am Coll Cardiol. 2022;79:1474-1476.
    PubMed        
    
    
68. REGENSTEINER JG, Reusch JEB
    Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and Diabetes: JACC Focus Seminar 4/7.
    J Am Coll Cardiol. 2022;79:1492-1505.
    PubMed         Abstract available
    
    
69. MENTIAS A, Aminian A, Youssef D, Pandey A, et al
    Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
    J Am Coll Cardiol. 2022;79:1429-1437.
    PubMed         Abstract available
    
    
70. POWELL-WILEY TM, Osei Baah F, Thompson K
    Bariatric Surgery and Cardiovascular Outcomes: What Can We Learn From More Representative Cohorts?
    J Am Coll Cardiol. 2022;79:1438-1440.
    PubMed        
    
    
71. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

72. GITTO M, Kotinas AS, Terzi R, Oliva A, et al
    Biochemical efficacy of sodium-glucose cotransporter 2 inhibitors by cardiovascular risk profile and volume status in a real-world diabetic population.
    J Cardiovasc Pharmacol. 2022 Apr 14. pii: 00005344-990000000-00025.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

73. SUZUKI Y, Kaneko H, Okada A, Matsuoka S, et al
    Prediabetes in Young Adults and Its Association with Cardiovascular Health Metrics in the Progression to Diabetes.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6572042. doi: 10.1210.
    PubMed         Abstract available
    
    
74. CUKIERMAN-YAFFE T, Gerstein HC, Basile J, Bethel MA, et al
    Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6569991. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Nucl Med

75. LASSEN ML, Byrne C, Sheykhzade M, Wissenberg M, et al
    Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia.
    J Nucl Med. 2022;63:431-437.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

76. ONOHARA D, Corporan DM, Kono T, Kumar S, et al
    Ventricular reshaping with a beating heart implant improves pump function in experimental heart failure.
    J Thorac Cardiovasc Surg. 2020 Sep 3. pii: S0022-5223(20)32535.
    PubMed         Abstract available
    
    
77. RAMZY D, Chikwe J
    Commentary: Is robotic-assisted coronary bypass ready for prime time?
    J Thorac Cardiovasc Surg. 2022;163:1848-1850.
    PubMed        
    
    
78. RAM E, Raanani E, Klempfner R, Peled Y, et al
    Midterm outcomes of patients with multivessel disease treated at centers with and without on-site cardiac surgery services.
    J Thorac Cardiovasc Surg. 2022;163:1852-1861.
    PubMed         Abstract available
    
    
79. PATEL NC, Hemli JM, Seetharam K, Singh VP, et al
    Minimally invasive coronary bypass versus percutaneous coronary intervention for isolated complex stenosis of the left anterior descending coronary artery.
    J Thorac Cardiovasc Surg. 2022;163:1839-1846.
    PubMed         Abstract available
    
    
80. LIAKOPOULOS OJ, Choi YH
    Commentary: Minimally invasive coronary bypass or percutaneous coronary intervention for complex left anterior descending artery stenosis: A never-ending battle.
    J Thorac Cardiovasc Surg. 2022;163:1850-1851.
    PubMed        
    
    

    
    JAMA

81. ABBASI J
    Highlights From the American College of Cardiology's Scientific Sessions-New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy.
    JAMA. 2022 Apr 20. pii: 2791572. doi: 10.1001/jama.2022.5487.
    PubMed        
    
    

    
    Mayo Clin Proc

82. DE SOUZA E SILVA CG, Buginga GC, de Souza E Silva EA, Arena R, et al
    Prediction of Mortality in Coronary Artery Disease: Role of Machine Learning and Maximal Exercise Capacity.
    Mayo Clin Proc. 2022 Apr 14. pii: S0025-6196(22)00046.
    PubMed         Abstract available
    
    

    
    N Engl J Med

83. PITT B, Joseph A, Schloemer P
    Cardiovascular Events with Finerenone in CKD and Diabetes. Reply.
    N Engl J Med. 2022;386:e43.
    PubMed        
    
    
84. ORTIZ A, Sarafidis P, Ferro CJ
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    PubMed        
    
    
85. GERARD AO, Laurain A, Esnault VLM
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    PubMed        
    
    
86. KAO PH, Hsu LC
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    PubMed        
    
    

    
    PLoS Comput Biol

87. FASSINA D, Costa CM, Longobardi S, Karabelas E, et al
    Modelling the interaction between stem cells derived cardiomyocytes patches and host myocardium to aid non-arrhythmic engineered heart tissue design.
    PLoS Comput Biol. 2022;18:e1010030.
    PubMed         Abstract available
    
    

    
    PLoS One

88. NAKAI M, Iwanaga Y, Sumita Y, Wada S, et al
    Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset.
    PLoS One. 2022;17:e0264390.
    PubMed         Abstract available
    
    
89. CASSELBRANT A, Fedorowski A, Frantz S, Engstrom G, et al
    Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease.
    PLoS One. 2022;17:e0264376.
    PubMed         Abstract available
    
    

    
    Thromb Haemost

90. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
    Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: